Thor Medical ASA (8NN.F)
Frankfurt · EUR · Healthcare · Biotechnology
€0.4055 (+1.37%) as of
Key statistics
- Market cap
- 171.32M
- EPS (TTM)
- -0.0200
- Dividend yield
- 0.00%
- 52-week range
- 0.2920 – 0.6480
- Beta
- -0.01
- Revenue (TTM)
- 1.64M
- Profit margin
- 0.00%
- Volume
- 100.00
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Oslo, Norway
- Employees
- 24
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.